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ABSTRACT
Background: Vitamin D binding protein, encoded by the GC gene (on 4q13.3), plays an important role in 
transporting vitamin D. Several Genome-Wide Association Studies (GWASs) have established a significant 
association between variants of GC gene and circulating vitamin D.
Objective: This study aims to determine the association of GC gene polymorphisms with vitamin D concentrations 
in young healthy Arab females.
Methodology: 214 female subjects from Qatar University were enrolled in this cross-sectional study. The cut-off 
value for optimal vitamin D levels was set at 30 ng/mL. The serum vitamin D was measured using ELISA, the 
genotyping of SNPs (rs2298850, rs3755967, rs2282679, rs7041, rs1155563, and rs17467825) of GC gene was 
performed by TaqMan assay, and the data was analyzed using SPSS software.
Results: The mean age of 214 participants was found to be 21.97 years. Of these, only 182 subjects were included 
in this study. The data showed that 14.8% were found to have optimal vitamin D levels and 85.2% with sub-
optimal levels. All studied SNPs were in HWE except SNPs rs7041 and rs1155563. Using the dominant model for 
rs2298850, the odds ratio to have low vitamin D is 1.48 (p=0.419). Similarly, rs3755967 has a risk of 1.62 (p=0.294); 
rs2282679 has an odds ratio of 1.32 (p=0.549); and rs17467825 with a risk of 1.48 (p=0.40). The genotypes for 
vitamin D levels had no significant difference (p>0.05) for all study subjects.
Conclusion: The current data showed no significant association between risk alleles of SNPs (rs2298850, rs3755967, 
rs2282679, rs7041, rs1155563, and rs17467825) with vitamin D levels.
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INTRODUCTION 
Vitamin D, a hormone belongs to a class of steroid derivatives called 
the secosteroids which are soluble in fat and available through 
certain foods and dietary supplements. The two most significant 
forms of Vitamin D are vitamin D2 (ergocalciferol) and vitamin D3 
(cholecalciferol), which are obtained from generic supplements, 
UV-irradiated mushrooms, and fatty fish sources. Unlike other 
vitamins, it is synthesized in the human skin from exposure to UVB 
rays from the sun, on its precursor 7-dehydrocholesterol. After 
synthesis, it is acted upon by the enzymes in the liver hepatocytes 
to produce 25-(OH)D(calcifediol). This product undergoes further 
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determine the association between genetic variants of GC gene at 
4q13.3 and vitamin D concentration in healthy, adult females.
MATERIALS AND METHODS
Study Participants
This research study is both prospective and retrospective. The 
ethics approval for participation of human subjects was granted 
by Qatar University Institutional Review Board (QU-IRB 531-
A/15). This study involved 214 healthy, female college students 
of Qatar University, who were enlisted through the university’s 
broadcast emails, social media platforms, and health awareness 
events like the World Diabetes Day and Vitamin D Awareness 
Day held on campus. Participating students were encouraged to 
fill out a Doodle survey to plan their sample donations. Amidst the 
analysis of results, quite a few data were excluded from the study 
based on the eligibility criteria for inclusion like ethnicity and 
liver functions. Since this study’s objective was to investigate the 
association of SNPs in the GC gene with vitamin D levels in the 
healthy female Arab population, subjects with non-Arab descents 
and those who are pregnant, lactating, taking vitamin D or calcium 
supplements within the last three months, and those with renal, 
hepatic, and autoimmune disorders were excluded.
Methods
The flowchart (supplementary figure S1) presents a concise outline 
of the methods employed in this study. The concentration of 25-
(OH)D was measured by enzyme-linked immunosorbent assay 
(ELISA) kit, supplied by GENATAUR (Kampenhout, Belgium). 
The extraction of DNA from blood was performed using QIAamp 
DNA blood mini kit, provided by QIAGEN (Hilden, Germany). 
Lastly, the SNP genotyping was carried out by TaqMan SNP 
Genotyping kit, provided by Life Technologies and Applied 
Biosystems (Foster City, California).
Blood Collection and Sample Separation
Before their participation and blood sample donations, the 
volunteers were informed about the study objectives and benefits 
and risks involved during the procedure. They were, then, 
requested to fill out a questionnaire and sign a consent form. 
Blood samples were collected by using the purple EDTA tubes. 
A certified phlebotomist collected 10 mL of venous blood from 
students fasting overnight. Then, the samples were centrifuged at 
3010 RPM for 10 minutes by ALC PK110 centrifuge. The plasma 
was subsequently separated and stored at -20 ˚C for vitamin D 
measurements that followed. Biochemical assays for glucose, 
lipid profile, triglycerides, insulin and interleukin (IL-6) were 
performed in biomedical labs as per the provided instructions of 
manufacturers.
Vitamin D Concentration Measurements
To increase the sensitivity and specificity of vitamin D detection, 
ELISA was utilized to measure both vitamin D2 and vitamin D3 
(supplementary figure S2). The vitamin D ELISA microtiter plate 
provided by GENTAUR was covered with monoclonal antibodies: 
anti-25-(OH)D2 and anti-25-(OH)D3. These antibodies then 
reacted with vitamin D2 and vitamin D3 in the samples, calibrator, 
and control. The microplate was washed to remove excess unbound 
vitamin D. It was followed by treating vitamin D labeled with biotin 
hydroxylation in the kidney to form the final product called 
1,25-(OH)2D(calcitriol), which circulates the blood vessels in its 
active form [1].
With the help of parathyroid hormone (PTH), calcitriol is 
essential for regulating calcium and phosphorus levels in the 
body and assisting with bone development. High PTH correlates 
with decreased 1,25-(OH)2D and consequently, low calcium 
secretion and absorption, leading to vitamin D deficiency. The 
human body then stimulates PTH to trigger the maturation of 
bone cells, or osteoclasts, which then secrete calcium from the 
bone (bone resorption) into the blood to alleviate hypercalcemia. 
Consequently, the bones become softer and porous, eventually 
giving rise to osteoporosis [2]. Vitamin D also regulates the immune 
system, cardiovascular system, and glucose homeostasis [3].
Melanin, a dark pigment in the skin produced as a result of 
melanocytes exposed to UV radiation, contributes to reduced sun 
exposure. Those with darker skin, such as the African American 
population, are more prone to low levels of vitamin D due to 
high melanin than their Caucasian counterparts [4]. Certain 
conditions that affect intestinal functions, such as Crohn’s disease, 
inflammatory bowel diseases, ulcerative colitis, cystic fibrosis, etc. 
causes malabsorption of fats, thus inducing vitamin D deficiency 
[1]. Additionally, liver dysfunction dramatically impacts vitamin 
D hydroxylation. For example, hepatic cirrhosis because of viral 
infection or abusive alcohol consumption causes severe vitamin D 
deficiency in patients due to extensive damage to their liver cells 
[5]. Like the liver, diseases of the kidneys considerably affect the 
hydroxylation process by altering the functions of renal enzymes. 
As the chronic renal diseases progress, creatinine clearance falls 
with diminishing glomerular filtration rates, and consequently, 
decreasing vitamin D levels [4].
The vitamin D binding protein (DBP) is a primary carrier of the 
metabolites of vitamin D (25-(OH)D and 1,25-(OH)2D) to target 
organs. DBP is encoded by 35 kb-long GC gene on chromosome 
4q13.3 [6]. Structural changes in the DBP due to mutations in GC 
gene results in suboptimal levels of vitamin D. Single nucleotide 
polymorphisms (SNPs) can affect gene expression by modification 
of mRNA splicing and disturb the structure and stability of 
proteins. Consequently, the protein functions and cellular 
responses by target cells will be significantly affected [7]. rs7041 and 
rs4588 are the two most common SNPs known to affect vitamin 
D concentrations. Studies are still being conducted on the other 
SNPs scattered throughout the GC gene that are thought to affect 
serum 25(OH) D levels [6].
According to the values set by the Endocrinology Society, all age 
groups in Europe, Canada, and the United States have approximately 
the same increased risk of developing vitamin D insufficiency and 
deficiency. Despite having sufficient sun exposure, low levels of 
vitamin D is commonly known to be widespread in places closer 
to the equator such as South America, Africa, the Middle East, 
India, and Australia [8]. Qatar, in the Middle East, reports 90 % 
of its population with suboptimal serum 25-(OH) D levels, due to 
inadequate dietary choices, genetics, lifestyle, religious and cultural 
factors. Furthermore, males in this region are found to be less 
deficient than females, due to the choice of clothing limiting the 
sun exposure and in turn, correlating with hypovitaminosis D [9].
Based on previous publications, it is hypothesized that the genetic 
polymorphisms in the GC gene will significantly affect the vitamin 
D levels in the studied cohort. The aim of this study was to 
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and horseradish peroxidase (HRP). This created a competition 
between vitamin D (in samples, control, and calibrator) and 
biotin-labeled vitamin D to bind with monoclonal antibodies. The 
microplate was incubated and then washed again. A chromogenic 
solution was added and the microplate incubated once more. In 
the end, a stop solution was added to cease the reaction and the 
absorbance of microplate read at 450 nm by a spectrophotometer. 
The absorbance remained inversely proportional to the total 25-
(OH)D concentration. The concentration of total vitamin D 
samples was decided by plotting a calibration curve. The results 
interpreted were in accordance with clinical chemistry laboratories 
of Hamad Medical Corporation, which followed the vitamin 
D status reference values of Endocrinology Society. They are as 
follows: sufficiency: >30 ng/mL, insufficiency: 21-29 ng/mL, and 
deficiency: ≤ 20 ng/mL [8].
DNA Extraction
The lysis buffer was added to the blood samples to degrade the cell 
membrane of the white blood cells and centrifuged to separate and 
discard the cell lysates, or pellet. The proteins that remained in the 
supernatant were lysed by the addition of proteases. Lastly, ethanol 
was used to purify the DNA from the samples.
QIAamp DNA blood mini kit, catalog number 151048063, was 
used for DNA extraction. To each Eppendorf tube, 200 µL of 
blood and 20 µL of protease (ratio of 10:1 sample to protease) was 
added and mixed by micropipette. Then, lysis buffer (200 µL) was 
added to each tube and mixed by vortex for 15 seconds; the tubes 
then incubated for 10 minutes at 56 ˚C. After that, the tubes were 
centrifuged at 12000 RPM, followed up by the addition of ethanol 
and vortexing for 15 seconds.
SNP Genotyping
To identify the polymorphisms in GC gene (supplementary table 
S1), the TaqMan genotyping kit was used. The selected SNPs were 
known for their associations with DBP expression and vitamin D 
serum levels, as reported by previous studies [10-14].
Manual calculations (supplementary table S2) were performed to 
determine the amount of each component to be used from the 
genotyping kit. Before placing samples in the 96-well reaction plates, 
the TaqMan Master Mix, nuclease-free water, and 40x TaqMan 
SNPs (rs2298850, rs3755967, rs2282679, rs7041, rs1155563, 
and rs17467825) were sufficiently mixed by the vortex. To ensure 
no DNA contamination, one of the wells in each plate served as 
a negative control. Thereafter, 23 µL from the reaction solution 
and 2 µL of sample DNA was added to each well separately. The 
solution was then mixed by micropipette, the microplates covered, 
and PCR amplification performed by automated real-time PCR 
equipment. The thermal cycles were adjusted according to the 
protocol set by TaqMan SNP genotyping assay.
Statistical Analysis
Statistical analyses were carried out using IBM SPSS Statistics 
version 24 for Windows [15]. The phenotypic distribution of 
the cohort was represented by the mean and standard deviation 
(for continuous data), and frequency count and percentage 
(for categorical data) to assess the normal distribution curve. 
Independent samples t-test was employed to build an association 
between three groups (total subjects, optimal vitamin D subjects, 
and sub-optimal vitamin D subjects) and phenotype characteristics. 
The Pearson’s Chi-square test was used to evaluate the Hardy-
Weinberg equilibrium (HWE), calculate genotypic frequencies (or 
distribution), likelihood ratio, and the call rate to determine the 
quality of the selected SNPs. MedCalc statistical software was used 
to compute the odds ratio (OR) and the 95% confidence intervals 
(CI) [16]. The data in all tests were interpreted using two-tailed 
P-values, and the statistical significance value was set at P<0.05. 
Dominant and recessive genetic models were constructed to check 
for any significance. These models were used to perform a linear 
regression to account for confounding factors and establish a 
relationship between vitamin D levels (as the dependent variable) 
and associated phenotypes (as independent variables). Microsoft 
Excel 2016 aided in plotting bar graphs, and GraphPad Prism 7 in 
creating odds ratio distribution [17,18].
RESULTS
General Study Characteristics 
The prevalence of vitamin D levels was assessed using SPSS and 
composed of two groups; subjects with optimal vitamin D levels (>30 
ng/mL) and suboptimal vitamin D levels (insufficient/deficient 
with <30 ng/mL). As shown in Figure 1, 182 female subjects were 
enrolled in this study, with 27 (14.8%) subjects having optimal 
levels of Vitamin D, and 155 (85.2%) subjects having insufficient 
(n=17; 9.4%) or deficient levels (n=138; 75.8%).
Phenotypic Characteristics
This cohort was composed of subjects with an average age of 22 
years old having a mean BMI of 26.35 kg/m2 and 85.66 cm for 
waist circumference. A comparison was made between the two 
vitamin D groups using statistical methods. As shown in Table 1, 
the data demonstrated that the group with sub-optimal levels has 
significantly lower mean values for Vitamin D levels (p=0.000); 
HDL (p=0.021); and triglycerides (p=0.009) than the subjects with 
the optimal group. On the contrary, subjects with sub-optimal 
vitamin D levels have significantly higher mean values for BMI 
(p=0.003) and waist circumference (p=0.010), than the subjects 
with optimal level. No significance difference (p>0.05) was found 
for other variables such as OWOB (p=0.091), IL-6 concentration 
(p=0.283), glucose (p=0.599), insulin (p=0.526), cholesterol 
(p=0.073), and LDL (p=0.289).
Genotype Distribution of Studied SNPs in Vitamin D Status 
Groups (Optimal and Sub-optimal)
There are six SNPs that were analyzed in this study: rs2298850, 
rs3755967, rs2282679, rs7041, rs1155563, and rs17467825 
of GC gene on chromosome 4q13.3. The Hardy–Weinberg 
equilibrium (HWE-P) was evaluated for the studied SNPs. As 
shown in supplementary table S3, HWE P-values for rs7041 
and rs1155563 were less than 0.05, so they were not used in 
further analyses and interpretation of the findings. Pearson’s 
Chi-Square test prompted the evaluation of frequencies of 
observed genotypes, and likelihood/risk ratio (χ²) was used to 
determine the probability of data.  Call rate (93.46%) indicated 
a successful analysis of SNP genotyping assay. The current data 
showed no significant difference (p>0.05) in the distribution 
of the genotypes in the following SNPs with respect to Vitamin 
D level status: rs2298850 (p=0.655; χ²=1.154), rs3755967 
(p=0.505; χ²=1.825), rs2282679 (p=0.739; χ²=0.903), rs7041 
(p=0.576; χ²=0.327), and rs17467825 (p=0.627; χ²=1.242).  
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Figure 1: Illustration of the distribution of Vitamin D status among the study subjects, for three groups (optimal, insufficient, and deficient).
As seen in Table 2 and Figures 2a-f, for all subjects in optimal and 
sub-optimal groups, the predominant genotype for rs2298850 is 
CC homozygous with G as the minor allele (14.84%). The SNPs 
rs3755967 and rs17467825 have predominant AA homozygous 
and G for the minor allele (18.13% and 17.03%, respectively). 
rs2282679 has CC homozygous as the most prevalent genotype 
and minor allele A (15.93%). rs7041 has GT heterozygous as 
the predominant genotype and minor allele T (40.66%). Lastly, 
rs1155563 has the expression of CT heterozygous alone with no 
major or minor allele (C:50%, T:50%). Similarly, the genotypic 
distribution of the SNPs was obtained for optimal, insufficient, 
and deficient groups of vitamin D (see supplement 4).
Association of Genetic Models with Vitamin D Status (Optimal 
and Sub-optimal)
Using the genotype frequencies for each SNP (Table 2), the MAF 
obtained was employed to construct dominant and recessive 
models. For rs1155563, dominant and recessive models could not 
be constructed since all samples have CT as the genotype, with no 
major or minor allele.  Table 3 shows no significant association 
with vitamin D status among the study subjects (p>0.05) for both 
genetic models for the following five SNPs: rs2298850 (Dominant, 
p=0.43; Recessive, p=0.94), rs3755967 (Dominant, p=0.31; 
Recessive, p=0.88), rs2282679 (Dominant, p=0.56; Recessive, 
p=0.94), rs7041 (Dominant, p=0.58; Recessive, p=0.39), and 
rs17467825 (Dominant, p=0.40; Recessive, p=0.94). Table 3 and 
supplementary figures S3 & S4 shows the odds of getting low 
vitamin D level below the optimal level expressed as odds ratio and 
95% CI.
Vitamin D Levels Based on the Genotype
The data (supplementary table S4) were analyzed by ANOVA, with 
the post-hoc test for multiple Dunnett’s comparisons between 
different genotypes. This post-hoc test revealed no significant 
differences (p>0.05) between the pair-wise genotypic groups of the 
studied SNPs, and the intergroup difference was not significant 
as follows: rs2298850 (p=0.739), rs3755967 (p=0.403), rs2282679 
(p=0.707), rs7041 (p=0.307), and rs17467825 (p=0.719). 
Correlation Coefficient between the Vitamin D Level and the 
Phenotypic Characteristics of the Study Subjects 
The vitamin D level of this study, which is a dependent factor, 
was evaluated for its correlations with other independent factors 
or variables (supplementary tables S5 & S6). It was found that 
the independent variables such as age, BMI, OWOB, waist 
Variables
Total number of  
subjects n=182
Optimal Vitamin D  
Levels (>30 ng/mL) n=27
Sub-optimal Vitamin D Levels  
(<30 ng/mL; insufficient or deficient)  
n= 155
P-value  
(2-tailed)
Vitamin D level(ng/mL) 14.88(14.67) 45.46(10.19) 9.66(6.33) 0.000*
Age(yrs.) 21.97(3.29) 21.93(3.46) 21.90(3.19) 0.967
BMI(kg/m2) 26.35 (6.89) 23.07(3.71) 27.20(7.15) 0.003*
OWOB 88 (48.4%) 9(33.3%) 79(51.0%) 0.091
Waist Circumference(cm) 85.66(13.29) 80.07(10.20) 87.05(13.41) 0.010*
Glucose(mmol/L) 4.99(0.47) 5.03(0.38) 4.97(0.49) 0.599
Cholesterol(mmol/L) 3.99(1.16) 4.36(0.81) 3.93(1.21) 0.073
LDL(mmol/L) 2.31(1.05) 2.52(0.67) 2.29(1.10) 0.289
HDL(mmol/L) 1.30(0.41) 1.46(0.33) 1.26(0.42) 0.021*
Triglycerides(mmol/L) 0.82(0.46) 0.85(0.28) 0.82(0.49) 0.009*
Insulin(µmol/L) 8.93(5.82) 12.35(5.29) 8.46(5.65) 0.526
IL-6 Concentration(pg/mL) 3.08(3.25) 2.47(0.96) 3.21(3.49) 0.283
Note: * represents statistical significance (p<0.05). The data shown here represent the mean and standard deviation for numerical variables. The 
number and percentage were used for categorical values, such as OWOB (overweight and obese). 
Table 1: Phenotype characterization of contributing factors of Vitamin D levels in this cohort.
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SNP Vitamin D Status A/a MAF (%) P-value
Subject’s n (%) P-value Likelihood 
RatioCC CR RR Dominant Recessive
rs2298850
Total subjects (n=182)
G/C
14.84%
0.655
130 
(71.4%)
50 (27.5%) 2 (1.1%)
0.43 0.94 1.154
Optimal Vitamin D 
subjects (n=27)
11.11% 21 (77.8%) 6 (22.2%) 0 (0.0%)
Sub-optimal Vitamin D 
subjects (n=155)
15.48%
109 
(70.3%)
44 (28.4%) 2 (1.3%)
rs3755967
Total subjects (n=182)
G/A
18.13%
0.505
119 
(65.4%)
60 (33.0%) 3 (1.6%)
0.31 0.88 1.825
Optimal Vitamin D 
subjects (n=27)
12.96% 20 (74.1%) 7 (25.9%) 0 (0.0%)
Sub-optimal Vitamin D 
subjects (n=155)
19.03% 99 (63.9%) 55 (34.2%) 3 (1.9%)
rs2282679
Total subjects (n=182)
A/C
15.93%
0.739
126 
(69.2%)
54 (29.7%) 2 (1.1%)
0.56 0.94 0.903
Optimal Vitamin D 
subjects (n=27)
12.96% 20 (74.1%) 7 (25.9%) 0 (0.0%)
Sub-optimal Vitamin D 
subjects (n=155)
16.45%
106 
(68.4%)
47 (30.3%) 2 (1.3%)
rs7041
Total subjects (n=182)
T/G
40.66%
0.576
34 (18.7%) 148 (81.3%) 0 (0.0%)
0.58 0.39 0.327
Optimal Vitamin D 
subjects (n=27)
42.59% 4 (14.8%) 23 (85.2%) 0 (0.0%)
Sub-optimal Vitamin D 
subjects (n=155)
40.32% 30 (19.4%) 125 (80.6%) 0 (0.0%)
rs1155563
Total subjects (n=182)
C/T
50.00%
-
0 (0.0%)
182 
(100.0%)
0 (0.0%)
- - -
Optimal Vitamin D 
subjects (n=27)
50.00% 0 (0.0%) 27 (100.0%) 0 (0.0%)
Sub-optimal Vitamin D 
subjects (n=155)
50.00% 0 (0.0%)
155 
(100.0%)
0 (0.0%)
rs17467825
Total subjects (n=182)
G/A
17.03%
0.627
122 
(67.0%)
58 (31.9%) 2 (1.1%)
0.4 0.94 1.242
Optimal Vitamin D 
subjects (n=27)
12.96% 20 (74.1%) 7 (25.9%) 0 (0.0%)
Sub-optimal Vitamin D 
subjects (n=155)
17.74%
102 
(65.8%)
51 (32.9%) 2 (1.3%)
Table 2: Genotypic distribution and minor allele frequency (MAF), for each studied SNP for optimal and sub-optimal groups.
Figure 2a: Graphic representation of rs2298850 among optimal and sub-optimal Vitamin D groups.
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Figure 2b: Graphic representation of rs3755967 among optimal and sub-optimal Vitamin D groups.
Figure 2c: Graphic representation of rs2282679 among optimal and sub-optimal Vitamin D groups.
Figure 2d: Graphic representation of rs7041 among optimal and sub-optimal Vitamin D groups.
circumference, IL-6, and triglycerides showed insignificant negative 
correlation. In other words, the inverse linear relationship was 
seen with vitamin D; age (R=-0.042, p=0.574); BMI (R=-0.120, 
p=0.108); OWOB (R=-0.067, p=0.372); waist circumference (R=-
0.153, p=0.051); IL-6 (R=-0.090, p=0.310); and triglycerides (R=-
0.022, p=0.782). However, the correlation between vitamin D 
level with independent variables like glucose, cholesterol, LDL, 
HDL, and insulin showed an insignificant proportional linear 
relationship. Glucose (R=0.054, p=0.493); cholesterol (R=0.107, 
p=0.177); LDL (R=0.067, p=0.400); HDL (R=0.138, p=0.080); 
and insulin (R=0.182, p=0.051). The Pearson correlation values 
were calculated using bivariate correlation analysis and two-tailed 
P-value was significant at <0.05. 
Association between Vitamin D Level (ng/mL) as the Dependent 
Variable and the Phenotype and Genotypes as Independent Variables
Linear regression analysis (Table 4) was performed to find out 
the associations between vitamin D levels (dependent variable) 
7Sharif E et al,. OPEN ACCESS Freely available online
J Women’s Health Care, Vol. 8 Iss. 5 No: 477
Figure 2e: Graphic representation of rs1155563 among optimal and sub-optimal Vitamin D groups.
Figure 2f: Graphic representation of rs17467825 among optimal and sub-optimal Vitamin D groups.
Category Genetic Model Genotype Odds Ratio 95% CI P-value
rs2298850
Dominant
GG+CG
1.48 0.56–3.90 0.419
CC
Recessive
CC+CG
1.12 0.05–23.89 0.94
GG
rs3755967
Dominant
GG+AG
1.62 0.64–4.06 0.294
AA
Recessive
AA+AG
0.79 0.04–15.77 0.88
GG
rs2282679
Dominant
AA+AC
1.32 0.52–3.33 0.549
CC
Recessive
CC+AC
1.12 0.05–23.89 0.94
AA
rs7041
Dominant
TT+GT
0.72 0.23–2.25 0.58
GG
Recessive
GG+GT
5.65 0.10–291.01 0.39
TT
rs17467825
Dominant
GG+AG
1.48 0.59–3.73 0.4
AA
Recessive
AA+AG
1.12 0.05–23.89 0.94
GG
Note: The statistical significance was set at p<0.05.
Table 3: Genetic models constructed for each SNP and determination of the risk allele/genotype by odds ratio.
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and various selected independent variables; BMI, WC, HDL, 
TG, rs2298850, rs3755967, rs2282679, and rs17467825 in 
their dominant models. They all showed P-values >0.05 which is 
insignificant. The data indicate that all independent variables are 
not significantly associated or have no effect on vitamin D level.
DISCUSSION
The deficiency in vitamin D levels has become a main global issue 
in the world, with children and adults of all ages equally at elevated 
risk. Vitamin D is a steroid hormone and is essential for immunity, 
bone development, reduction of cancer risk and other vital functions. 
It is transported in the human body by the DBP which is encoded 
by GC gene. The genetic variations (SNPs) affect the expression of 
DBP and hence, decrease vitamin D level in blood. This study was 
conducted to look for the association between SNPs and the vitamin 
D concentrations, in healthy young adult Arab females.
The vitamin D level was measured in 182 female subjects, out of 
which 14.8% of them showed an optimal level of vitamin D (>30 
ng/mL), while 85.2% of subjects showed a low level of vitamin 
D (<30 ng/mL). Such a large percentage is indicative that most 
participants suffer from vitamin D deficiency. These findings agree 
with a study done in Saudi Arabia, which showed that vitamin D 
deficiency was present in 87.6 % and insufficiency in 7.7% of the 
participants [13].
The phenotypic characteristics were analyzed for all subjects in this 
study. The present data demonstrated subjects with low vitamin 
D levels are associated with obesity phenotypes such as BMI and 
central obesity by waist circumference and with dyslipidemia 
(decreased HDL and high TG). A study that was done in Kuwait by 
Elkum et al. showed Arabs with high mean significant BMI and age 
(p<0.0001) with sub-optimal vitamin D levels. Likewise, the results 
were similar for BMI in this study, but the age was found to be an 
insignificant contributor to low-level of vitamin D [10].
In this study, the association between the genetic variants (SNPs) 
in GC gene and vitamin D level was investigated in adult female 
participants, who were healthy with no diseases or conditions 
impairing vitamin D metabolism. The most studied genetic variants 
or SNPs (rs2298850, rs3755967, rs2282679, rs7041, rs1155563, 
and rs17467825) were included in this study. Since rs7041 and 
rs1155563 deviated from the HWE, they were not included in 
the interpretation of the correlation and regression analyses. The 
major finding of the present study is that all the above four SNPs 
(rs2298850, rs3755967, rs2282679, and rs17467825) in the GC 
gene were found to be insignificantly contributing to the low-level 
of vitamin D in adult females.  
The data presented for rs2298850 in this cohort did not show 
any significant association between vitamin D levels, with G 
as the risk allele. On the other hand, the findings of Elkum et 
al.’s study showed statistical significance with vitamin D, among 
Arabs (p=0.0374) and South Asians (p=0.0103) living in Kuwait; 
however, with C as the risk allele. The dissimilarity between the 
present research and Kuwait’s study could be because of inclusion 
of large sample size consisting of both genders and a broad age 
group in the latter study, in contrast with the current study [10]. 
For SNP rs3755967, the current data showed no statistical 
significance with G as the risk allele among young Arab females. 
However, Suaini et al. found that rs3755967 was significantly 
associated with insufficient vitamin D level (risk allele A) in 
Caucasian infants in Australia. The obvious difference between 
their data and the present data is the ethnicity and age group [14]. 
In this study, rs2282679 has no significant association with serum 
25(OH)D (minor allele A). This finding is different from the study 
by Elkum et al. who showed that rs2282679 (minor allele T) is 
significant in affecting vitamin D level in Arabs in Kuwait [10]. In 
their study, vitamin D was measured in Arabs and South Asian, and 
included both genders male and female. Five SNPs (rs17467825, 
rs3755967, rs2282679, rs7041 and rs2298850) in the GC gene 
were investigated. All of them were found to be significantly 
associated with vitamin D level. On the other hand, rs7041 and 
rs2282679 were the only two that were significantly associated with 
affecting vitamin D level in both Arabs and South Asians. Here, 
the difference in ethnicity, age and gender influenced the action of 
SNP in the GC gene. However, another study done in King Fahd 
Hospital of the University in Saudi Arabia agrees with the present 
results. It was found that there was no significant association 
between rs2282679 (but with minor allele G) and vitamin D level 
[13].
The current data for rs7041 shows no significant association for 
this cohort, although several studies have proved its significance 
about vitamin D levels. For example, a study conducted by Wood 
et al. demonstrated statistical significance (p=0.01) with serum 
vitamin D, risk allele T, in the United Kingdom’s Caucasian 
subjects with α-1 antitrypsin deficiency. The discrepancy arises due 
to the inclusion of a different ethnic group and unhealthy subjects 
[12].
For rs1155563, the current data did not present with any significant 
association with vitamin D, and the only genotype found was CT. 
However, the results of Elkum et al. contradict with the results of 
this cohort. In their study, rs1155563 demonstrated a significant 
association with vitamin D level (p=0.0289) among the Arab 
Independent Variable
β-Unstandardized 
Coefficient
Standard Error t value P-value
BMI -0.255 0.158 -1.615 0.108
WC -0.177 0.09 -1.964 0.051
HDL 5.194 2.944 1.764 0.08
TG -0.731 2.63 -0.278 0.782
rs2298850 -1.813 2.411 -0.752 0.453
rs3755967 -3.085 2.281 -1.352 0.178
rs2282679 -1.992 2.383 -0.836 0.404
rs17467825 -1.83 2.316 -0.79 0.43
Note: t-value = Unstandardized coefficient/Standard error. The statistical significance was set at p<0.05.
Table 4: Association of vitamin D levels and other independent factors.
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population, and CC, CT, and TT genotypes with C as the risk 
allele. The difference in results could be due to the inclusion of 
both genders and large age group [10].
There was no significant association found in SNP rs17467825 
with vitamin D levels (risk allele G) in this cohort. Similar 
studies done in healthy Danish children and adults revealed that 
rs17467825 (risk allele G) is significantly associated (p=0.0230) to 
serum vitamin D concentrations. The disparity occurs because of 
the involvement of a large age group, gender, and ethnicity [11].
Further studies should involve a larger sample size with bigger age 
group, to observe a significant association between the GC gene 
and vitamin D serum concentrations. Other SNPs in the GC 
gene should also be analyzed to find out if there is any significant 
association with vitamin D in this population. The countries in 
the Middle East are majorly dependent on international vitamin D 
definitions as set by the Endocrinology Society. Therefore, the cut-
off values for vitamin D status for this region can be re-evaluated to 
fit the Arab population better.
CONCLUSION
For the cohort studied in this research, the key finding revealed 
an insignificant association between vitamin D status and SNPs 
rs2298850, rs3755967, rs2282679, rs7041, rs1155563, and 
rs17467825. The current results of this study suggest that for 
healthy Arab young females, there are no genetic factors (in GC 
gene) associated with sub-optimal levels. On the contrary, it can 
be said that the physiological and environmental factors like an 
individual’s lifestyle and clothing choices and other genetic factors 
like mutations in renal and hepatic enzymes play an equally 
important role in defining the vitamin D status in this study.
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